Single nucleotide polymorphism in the cholesterol-24SHydroxylase (CYP46A1) Gene and Its association with CFH and LOC387715 gene polymorphisms in age-related macular degeneration

Investigative Ophthalmology and Visual Science

Volumn 53, Issue 11, 2012, Pages 7026-7033

  Fourgeux, Cynthia ^a,b,c   Dugas, Brice ^d   Richard, Florence ^e   Bjorkhem, Ingemar ^f   Acar, Niyazi ^a,b,c   Bron, Alain M ^a,b,c,d   Korobelnik, Jean François ^g   Leveziel, Nicolas ^h   Zerbib, Jennyfer ^h   Puche, Nathalie ^h   Creuzot Garcher, Catherine P ^a,b,c,d   Souied, Eric ^h   Bretillon, Lionel ^a,b,c  

^a CEMAGREF   (France)

^b CNRS   (France)

^c CENTRE DES SCIENCES DU GOÛT ET DE L ALIMENTATION   (France)

^d DIJON UNIVERSITY HOSPITAL   (France)

^e INSTITUT PASTEUR DE LILLE   (France)

^f KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^g BORDEAUX UNIVERSITY HOSPITAL   (France)

^h University Hospital   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; CHOLESTEROL DERIVATIVE; 24 HYDROXYCHOLESTEROL; 24-HYDROXYCHOLESTEROL; ARMS2 PROTEIN, HUMAN; CHOLESTEROL 24 HYDROXYLASE; CHOLESTEROL 24-HYDROXYLASE; COMPLEMENT FACTOR H; COMPLEMENT FACTOR H, HUMAN; PROTEIN; STEROID MONOOXYGENASE;

AGED; ARTICLE; CFH GENE; CHOLESTEROL 24S HYDROXYLASE GENE; CONTROLLED STUDY; FEMALE; GENE; GENE FREQUENCY; GENETIC RISK; GENOTYPE; GEOGRAPHIC ATROPHY; HUMAN; LOC387715 GENE; MAJOR CLINICAL STUDY; MALE; MASS FRAGMENTOGRAPHY; PRIORITY JOURNAL; RETINA MACULA AGE RELATED DEGENERATION; SINGLE NUCLEOTIDE POLYMORPHISM; ALLELE; BLOOD; EXUDATIVE MACULAR DEGENERATION; GENETICS; GENOTYPING TECHNIQUE; RISK; RISK FACTOR;

AGED; ALLELES; CHOLESTEROL; COMPLEMENT FACTOR H; FEMALE; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; GENOTYPING TECHNIQUES; GEOGRAPHIC ATROPHY; HUMANS; HYDROXYCHOLESTEROLS; MALE; ODDS RATIO; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTEINS; RISK FACTORS; STEROID HYDROXYLASES; WET MACULAR DEGENERATION;

EID: 84872180854     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.12-9652     Document Type: Article

References (94)

1. Klein R, Chou CF, Klein BEK, et al. Prevalence of age-related macular degeneration in the US population. Arch Ophthalmol. 2011;129:75-80.
2. Ambati J, Ambati BK, Yoo SH, Ianchulev S, Adamis AP. Agerelated macular degeneration: etiology, pathogenesis, and therapeutic strategies. Surv Ophthalmol. 2003;48:257-293.
3. Zarbin MA. Current concepts in the pathogenesis of agerelated macular degeneration. Arch Ophthalmol. 2004;122: 598-614.
4. Holz FG, Pauleikhoff D, Klein R, Bird AC. Pathogenesis of lesions in late age-related macular disease. Am J Ophthalmol. 2004;137:504-510.
5. de Jong PT. Age-related macular degeneration. N Engl J Med. 2006;355:1474-1485.
6. Bird AC, Bressler NM, Bressler SB, et al. An international classification and grading system for age-related maculopathy and age-related macular degeneration. The International ARM Epidemiological Study Group. Surv Ophthalmol. 1995;39: 367-374.
7. Green WR, Enger C. Age-related macular degeneration histopathologic studies. The 1992 Lorenz E. Zimmerman Lecture. Ophthalmology. 1993;100:1519-1535.
8. Curcio CA, Johnson M, Huang JD, Rudolf M. Aging, age-related macular degeneration, and the response-to-retention of apolipoprotein b-containing lipoproteins. Progr Retin Eye Res. 2009;28:393-422.
9. Rudolf M, Clark ME, Chimento MF, et al. Prevalence and morphology of druse types in the macula and periphery of eyes with age-related maculopathy. Invest Ophthalmol Vis Sci. 2008;49:1200-1209.
10. Klein R, Klein BE, Knudtson MD, et al. Fifteen-year cumulative incidence of age-related macular degeneration: the Beaver Dam Eye Study. Ophthalmology. 2007;114:253-262.
11. Klein R, Davis MD, Magli YL, et al. The Wisconsin age-related maculopathy grading system. Ophthalmology. 1991;98:1128-1134.
12. Klein R, Peto T, Bird A, Vannewkirk MR. The epidemiology of age-related macular degeneration. Am J Ophthalmol. 2004; 137:486-495.
13. Klaver CC, Kliffen M, van Duijn CM, et al. Genetic association of apolipoprotein E with age-related macular degeneration. Am J Hum Genet. 1998;63:200-206.
14. Klein BE, Klein R, Lee KE, Moore EL, Danforth L. Risk of incident age-related eye diseases in people with an affected sibling: the Beaver Dam Eye Study. Am J Epidemiol. 2001;154: 207-211.
15. Seddon JM, Ajani UA, Mitchell BD. Familial aggregation of agerelated maculopathy. Am J Ophthalmol. 1997;123:199-206.
16. Smith W, Mitchell P. Family history and age-related maculopathy: the Blue Mountains Eye Study. Aust N Z J Ophthalmol. 1998;26:203-206.
17. Hammond CJ, Webster AR, Snieder H, et al. Genetic influence on early age-related maculopathy: a twin study. Ophthalmology. 2002;109:730-736.
18. Seddon JM, Cote J, Page WF, Aggen SH, Neale MC. The US twin study of age-related macular degeneration: relative roles of genetic and environmental influences. Arch Ophthalmol. 2005;123:321-327.
19. Gottfredsdottir MS, Sverrisson T, Musch DC, Stefansson E. Age related macular degeneration in monozygotic twins and their spouses in Iceland. Acta Ophthalmol Scand. 1999;77:422-425.
20. Grizzard SW, Arnett D, Haag SL. Twin study of age-related macular degeneration. Ophthalmic Epidemiol. 2003;10:315-322.
21. Anderson DH, Radeke MJ, Gallo NB, et al. The pivotal role of the complement system in aging and age-related macular degeneration: hypothesis re-visited. Progr Retin Eye Res. 2010;29:95-112.
22. Klein RJ, Zeiss C, Chew EY, et al. Complement factor H polymorphism in age-related macular degeneration. Science. 2005;308:385-389.
23. Thakkinstian A, Han P, McEvoy M, et al. Systematic review and meta-analysis of the association between complement factor H Y402H polymorphisms and age-related macular degeneration. Hum Mol Genet. 2006;15:2784-2790.
24. Gold B, Merriam JE, Zernant J, et al. Variation in factor B (BF) and complement component 2 (C2) genes is associated with age-related macular degeneration. Nat Genet. 2006;38:458-462.
25. Maller JB, Fagerness JA, Reynolds RC, et al. Variation in complement factor 3 is associated with risk of age-related macular degeneration. Nat Genet. 2007;39:1200-1201.
26. Yates JR, Sepp T, Matharu BK, et al. Complement C3 variant and the risk of age-related macular degeneration. N Engl J Med. 2007;357:553-561.
27. Fisher SA, Abecasis GR, Yashar BM, et al. Meta-analysis of genome scans of age-related macular degeneration. Hum Mol Genet. 2005;14:2257-2264.
28. Meyer K, Davis L, Schindler E, et al. Genome-wide analysis of copy number variants in age-related macular degeneration. Hum Genet. 2011;129:91-100.
29. Jakobsdottir J, Conley YP, Weeks DE, et al. Susceptibility genes for age-related maculopathy on chromosome 10q26. Am J Hum Genet. 2005;77:389-407.
30. Rivera A, Fisher SA, Fritsche LG, et al. Hypothetical LOC387715 is a second major susceptibility gene for agerelated macular degeneration, contributing independently of complement factor H to disease risk. Hum Mol Genet. 2005; 14:3227-3236.
31. DeWan A, Bracken MB, Hoh J. Two genetic pathways for agerelated macular degeneration. Curr Opin Genet Dev. 2007;17: 228-233.
32. Yang Z, Camp NJ, Sun H, et al. A variant of the HTRA1 gene increases susceptibility to age-related macular degeneration. Science. 2006;314:992-993.
33. Vierkotten S, Muether PS, Fauser S. Overexpression of HTRA1 leads to ultrastructural changes in the elastic layer of Bruch's membrane via cleavage of extracellular matrix components. PLoS ONE. 2011;6:e22959.
34. Jones A, Kumar S, Zhang N, et al. Increased expression of multifunctional serine protease, HTRA1, in retinal pigment epithelium induces polypoidal choroidal vasculopathy in mice. Proc Natl Acad Sci U S A. 2011;108:14578-14583.
35. Kanda A, Chen W, Othman M, et al. A variant of mitochondrial protein LOC387715/ARMS2, not HTRA1, is strongly associated with age-related macular degeneration. Proc Natl Acad Sci U S A. 2007;104:16227-16232.
36. Fliesler SJ, Anderson RE. Chemistry and metabolism of lipids in the vertebrate retina. Prog Lipid Res. 1983;22:79-131.
37. Fliesler SJ, Bretillon L. The ins and outs of cholesterol in the vertebrate retina. J Lipid Res. 2010;51:3399-3413.
38. Bretillon L, Thuret G, Grégoire S, et al. Lipid and fatty acid profile of the retina, retinal pigment epithelium/choroid, and lacrimal gland, and associations with adipose tissue fatty acids in human subjects. Exp Eye Res. 2008;87:521-528.
39. Lutjohann D, Breuer O, Ahlborg G, et al. Cholesterol homeostasis in human brain: evidence for an age-dependent flux of 24S-hydroxycholesterol from the brain into the circulation. Proc Natl Acad Sci U S A. 1996;93:9799-9804.
40. 2 techniques in vivo and in vitro. J Biol Chem. 1997;272:30178-30184.
41. Björkhem I, Lütjohann D, Diczfalusy U, et al. Cholesterol homeostasis in human brain: turnover of 24S-hydroxycholesterol and evidence for a cerebral origin of most of this oxysterol in the circulation. J Lipid Res. 1998;39:1594-1600.
42. Bretillon L, Diczfalusy U, Bjorkhem I, et al. Cholesterol-24Shydroxylase (CYP46A1) is specifically expressed in neurons of the neural retina. Curr Eye Res. 2007;32:361-366.
43. Ramirez DM, Andersson S, Russell DW. Neuronal expression and subcellular localization of cholesterol 24-hydroxylase in the mouse brain. J Comp Neurol. 2008;507:1676-1693.
44. Bjorkhem I. Crossing the barrier: oxysterols as cholesterol transporters and metabolic modulators in the brain. J Intern Med. 2006;260:493-508.
45. Mast N, Reem R, Bederman I, et al. Cholestenoic acid is an important elimination product of cholesterol in the retina: comparison of retinal cholesterol metabolism with that in the brain. Invest Ophthalmol Vis Sci. 2011;52:594-603.
46. Rodriguez IR, Larrayoz IM. Cholesterol oxidation in the retina: implications of 7KCh formation in chronic inflammation and age-related macular degeneration. J Lipid Res. 2010;51:2847-2862.
47. Hudry E, Van Dam D, Kulik W, et al. Adeno-associated virus gene therapy with cholesterol 24-hydroxylase reduces the amyloid pathology before or after the onset of amyloid plaques in mouse models of Alzheimer's disease. Mol Ther. 2010;18:44-53.
48. Halford RW, Russell DW. Reduction of cholesterol synthesis in the mouse brain does not affect amyloid formation in Alzheimer's disease, but does extend lifespan. Proc Natl Acad Sci U S A. 2009;106:3502-3506.
49. Borroni B, Archetti S, Agosti C, et al. Intronic CYP46 polymorphism along with ApoE genotype in sporadic Alzheimer disease: from risk factors to disease modulators. Neurobiol Aging. 2004;25:747-751.
50. Combarros O, Infante J, Llorca J, Berciano J. Genetic association of CYP46 and risk for Alzheimer's Disease. Dement Geriatr Cogn Disord. 2004;18:257-260.
51. Johansson A, Katzov H, Zetterberg H, et al. Variants of CYP46A1 may interact with age and APOE to influence CSF Abeta42 levels in Alzheimer's disease. Hum Genet. 2004;114: 581-587.
52. Kolsch H, Lütjohann D, Ludwig M, et al. Polymorphism in the cholesterol 24S-hydroxylase gene is associated with Alzheimer's disease. Mol Psychiatry. 2002;7:899-902.
53. Papassotiropoulos A, Streffer JR, Tsolaki M, et al. Increased brain beta-amyloid load, phosphorylated tau, and risk of Alzheimer disease associated with an intronic CYP46 polymorphism. Arch Neurol. 2003;60:29-35.
54. Wang B, Zhang C, Zheng W, et al. Association between a T/C polymorphism in intron 2 of cholesterol 24S-hydroxylase gene and Alzheimer's disease in Chinese. Neurosci Lett. 2004;369: 104-107.
55. Helisalmi S, Vepsalainen S, Koivisto AM, et al. Association of CYP46 intron 2 polymorphism in Finnish Alzheimer's disease samples and a global scale summary. J Neurol Neurosurg Psychiatry. 2006;77:421-422.
56. Ma SL, Tang NL, Lam LC, Chiu HF. Polymorphisms of the cholesterol 24-hydroxylase (CYP46A1) gene and the risk of Alzheimer's disease in a Chinese population. Int Psychogeriatr. 2006;18:37-45.
57. Fernández Del Pozo V, Alvarez Alvarez M, Fernández Martinez M, et al. Polymorphism in the cholesterol 24S-hydroxylase gene (CYP46A1) associated with the APOEpsilon3 allele increases the risk of Alzheimer's disease and of mild cognitive impairment progressing to Alzheimer's disease. Dement Geriatr Cogn Disord. 2006;21:81-87.
58. Li Y, Chu LW, Chen YQ, et al. Intron 2 (T/C) CYP46 polymorphism is associated with Alzheimer's disease in Chinese patients. Dement Geriatr Cogn Disord. 2006;22: 399-404.
59. Papassotiropoulos A, Wollmer MA, Tsolaki M, et al. A cluster of cholesterol-related genes confers susceptibility for Alzheimer's disease. J Clin Psychiatry. 2005;66:940-947.
60. Fu BY, Ma SL, Tang NL, et al. Cholesterol 24-hydroxylase (CYP46A1) polymorphisms are associated with faster cognitive deterioration in Chinese older persons: a two-year follow up study. Int J Geriatr Psychiatry. 2009;24:921-926.
61. Vega GL, Weiner M, Kolsch H, et al. The effects of gender and CYP46 and apoE polymorphism on 24S-hydroxycholesterol levels in Alzheimer's patients treated with statins. Curr Alzheimer Res. 2004;1:71-77.
62. Tedde A, Rotondi M, Cellini E, et al. Lack of association between the CYP46 gene polymorphism and Italian late-onset sporadic Alzheimer's disease. Neurobiol Aging. 2006;27: 773. e771-773. e773.
63. Ingelsson M, Jesneck J, Irizarry MC, Hyman BT, Rebeck GW. Lack of association of the cholesterol 24-hydroxylase (CYP46) intron 2 polymorphism with Alzheimer's disease. Neurosci Lett. 2004;367:228-231.
64. Kabbara A, Payet N, Cottel D, et al. Exclusion of CYP46 and APOM as candidate genes for Alzheimer's disease in a French population. Neurosci Lett. 2004;363:139-143.
65. Chalmers KA, Culpan D, Kehoe PG, et al. APOE promoter, ACE1 and CYP46 polymorphisms and beta-amyloid in Alzheimer's disease. Neuroreport. 2004;15:95-98.
66. Desai P, DeKosky ST, Kamboh MI. Genetic variation in the cholesterol 24-hydroxylase (CYP46) gene and the risk of Alzheimer's disease. Neurosci Lett. 2002;328:9-12.
67. Juhasz A, Rimanoczy A, Boda K, et al. CYP46 T/C polymorphism is not associated with Alzheimer's dementia in a population from Hungary. Neurochem Res. 2005;30:943-948.
68. Fourgeux C, Martine L, Björkhem I, et al. Primary open-angle glaucoma: association with cholesterol 24S-hydroxylase (CYP46A1) gene polymorphism and plasma 24-hydroxycholesterol levels. Invest Ophthalmol Vis Sci. 2009;50:5712-5717.
69. Dekaban AS. Changes in brain weights during the span of human life: relation of brain weights to body heights and body weights. Ann Neurol. 1978;4:345-356.
70. Urata K, Kawasaki S, Matsunami H, et al. Calculation of child and adult standard liver volume for liver transplantation. Hepatology. 1995;21:1317-1321.
71. Wynne HA, Cope LH, Mutch E, et al. The effect of age upon liver volume and apparent liver blood flow in healthy man. Hepatology. 1989;9:297-301.
72. Bretillon L, Lütjohann D, Stahle L, et al. Plasma levels of 24Shydroxycholesterol reflect the balance between cerebral production and hepatic metabolism and are inversely related to body surface. J Lipid Res. 2000;41:840-845.
73. Zerbib J, Seddon JM, Richard F, et al. rs5888 variant of SCARB1 gene is a possible susceptibility factor for age-related macular degeneration. PLoS One. 2009;4:e7341.
74. Bretillon L, Sidén A, Wahlund LO, et al. Plasma levels of 24Shydroxycholesterol in patients with neurological diseases. Neurosci Lett. 2000;293:87-90.
75. Haddad S, Chen CA, Santangelo SL, Seddon JM. The genetics of age-related macular degeneration: a review of progress to date. Surv Ophthalmol. 2006;51:316-363.
76. Dewan A, Liu M, Hartman S, et al. HTRA1 promoter polymorphism in wet age-related macular degeneration. Science. 2006;314:989-992.
77. Weger M, Renner W, Steinbrugger I, et al. Association of the HTRA1-625G>A promoter gene polymorphism with exudative age-related macular degeneration in a Central European population. Mol Vis. 2007;13:1274-1279.
78. Xu Y, Guan N, Xu J, et al. Association of CFH, LOC387715, and HTRA1 polymorphisms with exudative age-related macular degeneration in a northern Chinese population. Mol Vis. 2008; 14:1373-1381.
79. Hughes AE, Orr N, Patterson C, et al. Neovascular age-related macular degeneration risk based on CFH, LOC387715/HTRA1, and smoking. PLoS Med. 2007;4:e355.
80. Kaur I, Katta S, Hussain A, et al. Variants in the 10q26 gene cluster (LOC387715 and HTRA1) exhibit enhanced risk of agerelated macular degeneration along with CFH in Indian patients. Invest Ophthalmol Vis Sci. 2008;49:1771-1776.
81. Wang G, Scott WK, Whitehead P, et al. A novel ARMS2 splice variant is identified in human retina. Exp Eye Res. 2012;94: 187-191.
82. Kortvely E, Hauck SM, Duetsch G, et al. ARMS2 is a constituent of the extracellular matrix providing a link between familial and sporadic age-related macular degenerations. Invest Ophthalmol Vis Sci. 2010;51:79-88.
83. Laine M, Jarva H, Seitsonen S, et al. Y402H polymorphism of complement factor H affects binding affinity to C-reactive protein. J Immunol. 2007;178:3831-3836.
84. Fourgeux C, Bron A, Acar N, Creuzot-Garcher C, Bretillon L. 24S-hydroxycholesterol and cholesterol-24S-hydroxylase (CYP46A1) in the retina: from cholesterol homeostasis to pathophysiology of glaucoma. Chem Phys Lipids. 2011;164: 496-499.
85. Leoni V. Oxysterols as markers of neurological disease-a review. Scand J Clin Lab Invest. 2009;69:22-25.
86. Seet RCS, Lee CY, Loke WM, et al. Biomarkers of oxidative damage in cigarette smokers: which biomarkers might reflect acute versus chronic oxidative stress? Free Radic Biol Med. 2011;50:1787-1793.
87. Dashti N, McGwin G, Owsley C, Curcio CA. Plasma apolipoproteins and risk for age related maculopathy. Br J Ophthalmol. 2006;90:1028-1033.
88. Smith W, Assink J, Klein R, et al. Risk factors for age-related macular degeneration: pooled findings from three continents. Ophthalmology. 2001;108:697-704.
89. Carroll MD, Lacher DA, Sorlie PD, et al. Trends in serum lipids and lipoproteins of adults, 1960-2002. JAMA. 2005;294:1773-1781.
90. Maller J, George S, Purcell S, et al. Common variation in three genes, including a noncoding variant in CFH, strongly influences risk of age-related macular degeneration. Nat Genet. 2006;38:1055-1059.
91. Neale BM, Fagerness J, Reynolds R, et al. Genome-wide association study of advanced age-related macular degeneration identifies a role of the hepatic lipase gene (LIPC). Proc Natl Acad Sci U S A. 2010;107:7395-7400.
92. Reynolds R, Rosner B, Seddon JM. Serum lipid biomarkers and hepatic lipase gene associations with age-related macular degeneration. Ophthalmology. 2010;117:1989-1995.
93. Seddon JM, Reynolds R, Rosner B. Associations of smoking, body mass index, dietary lutein, and the LIPC gene variant rs10468017 with advanced age-related macular degeneration. Mol Vis. 2010;16:2412-2424.
94. Shafaati M, O'Driscoll R, Björkhem I, Meaney S. Transcriptional regulation of cholesterol 24-hydroxylase by histone deacetylase inhibitors. Biochem Biophys Res Commun. 2009;378: 689-694.